ATE553087T1 - Therapeutisches mittel gegen chronische obstruktive atemwegserkrankung und verfahren zur behandlung von chronisch obstruktiver atemwegserkrankung mit diesem mittel - Google Patents
Therapeutisches mittel gegen chronische obstruktive atemwegserkrankung und verfahren zur behandlung von chronisch obstruktiver atemwegserkrankung mit diesem mittelInfo
- Publication number
- ATE553087T1 ATE553087T1 AT04771118T AT04771118T ATE553087T1 AT E553087 T1 ATE553087 T1 AT E553087T1 AT 04771118 T AT04771118 T AT 04771118T AT 04771118 T AT04771118 T AT 04771118T AT E553087 T1 ATE553087 T1 AT E553087T1
- Authority
- AT
- Austria
- Prior art keywords
- chronic obstructive
- respiratory disease
- group
- obstructive respiratory
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003203699 | 2003-07-30 | ||
| PCT/JP2004/011013 WO2005012251A1 (ja) | 2003-07-30 | 2004-07-27 | 慢性閉塞性肺疾患治療剤及びそれを用いた慢性閉塞性肺疾患の治療方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE553087T1 true ATE553087T1 (de) | 2012-04-15 |
Family
ID=34113624
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04771118T ATE553087T1 (de) | 2003-07-30 | 2004-07-27 | Therapeutisches mittel gegen chronische obstruktive atemwegserkrankung und verfahren zur behandlung von chronisch obstruktiver atemwegserkrankung mit diesem mittel |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US8980914B2 (de) |
| EP (1) | EP1650191B1 (de) |
| KR (1) | KR101100659B1 (de) |
| CN (1) | CN100422155C (de) |
| AT (1) | ATE553087T1 (de) |
| AU (1) | AU2004261527B2 (de) |
| CA (1) | CA2533919C (de) |
| DK (1) | DK1650191T3 (de) |
| ES (1) | ES2382937T3 (de) |
| TW (1) | TWI344365B (de) |
| WO (1) | WO2005012251A1 (de) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2943725B2 (ja) * | 1996-01-17 | 1999-08-30 | 大日本インキ化学工業株式会社 | キノリノン誘導体及びそれを有効成分とする抗アレルギー剤 |
| US6624181B1 (en) * | 1997-02-28 | 2003-09-23 | Altana Pharma Ag | Synergistic combination |
| TW430656B (en) * | 1997-12-03 | 2001-04-21 | Dainippon Ink & Chemicals | Quinolinone derivative, method for preparing the same, and anti-allergic agent |
| KR100908418B1 (ko) * | 2001-06-20 | 2009-07-21 | 액티버스 파마 컴퍼니 리미티드 | 퀴놀리논 유도체 의약 조성물 및 그의 제조 방법 |
-
2004
- 2004-07-27 TW TW093122392A patent/TWI344365B/zh not_active IP Right Cessation
- 2004-07-27 AU AU2004261527A patent/AU2004261527B2/en not_active Ceased
- 2004-07-27 CA CA2533919A patent/CA2533919C/en not_active Expired - Fee Related
- 2004-07-27 ES ES04771118T patent/ES2382937T3/es active Active
- 2004-07-27 WO PCT/JP2004/011013 patent/WO2005012251A1/ja active Application Filing
- 2004-07-27 EP EP04771118A patent/EP1650191B1/de not_active Not-in-force
- 2004-07-27 DK DK04771118.9T patent/DK1650191T3/da active
- 2004-07-27 US US10/565,828 patent/US8980914B2/en active Active
- 2004-07-27 KR KR1020067001758A patent/KR101100659B1/ko active IP Right Grant
- 2004-07-27 CN CNB2004800217130A patent/CN100422155C/zh not_active Expired - Fee Related
- 2004-07-27 AT AT04771118T patent/ATE553087T1/de active
-
2015
- 2015-02-16 US US14/623,146 patent/US20150157621A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2533919A1 (en) | 2005-02-10 |
| CA2533919C (en) | 2010-10-12 |
| US20060235045A1 (en) | 2006-10-19 |
| ES2382937T3 (es) | 2012-06-14 |
| AU2004261527A1 (en) | 2005-02-10 |
| TWI344365B (en) | 2011-07-01 |
| US8980914B2 (en) | 2015-03-17 |
| CN1829693A (zh) | 2006-09-06 |
| EP1650191B1 (de) | 2012-04-11 |
| KR20060041286A (ko) | 2006-05-11 |
| AU2004261527B2 (en) | 2010-09-23 |
| DK1650191T3 (da) | 2012-05-07 |
| TW200509927A (en) | 2005-03-16 |
| EP1650191A4 (de) | 2008-08-20 |
| US20150157621A1 (en) | 2015-06-11 |
| CN100422155C (zh) | 2008-10-01 |
| WO2005012251A1 (ja) | 2005-02-10 |
| KR101100659B1 (ko) | 2012-01-03 |
| EP1650191A1 (de) | 2006-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA28010A1 (fr) | Derives de piperazine et leur utilisation comme agents therapeutiques | |
| ATE375341T1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
| DE60128258D1 (de) | Indanylderivate zur Behandlung von Atemwegserkrankungen | |
| DE602005007339D1 (de) | Nebivolol und dessen pharmazeutisch unbedenkliche salze, herstellungsverfahren und pharmazeutische zusammensetzungen von nebivolol | |
| PA8575401A1 (es) | Derivados de heteroarilamida benzocondensada de tienopiridinas utiles como agentes terapeuticos, composiciones farmaceuticas que incluyen a los mismos y metrodos para su uso | |
| UA85708C2 (ru) | Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей | |
| NO20062691L (no) | Azabicykliske heterocykler som cannabinoide reseptormodulatorer | |
| DE69521424D1 (de) | Benzofuran derivate und ihre verwendung als inhibitoren der knochenresorption | |
| ATE464299T1 (de) | Neues phenylalaninderivat | |
| NO20051209L (no) | Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk anvendelse derav samt intermediater for samme | |
| DE602004029580D1 (de) | Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen | |
| WO2005056524A3 (en) | Therapeutic agents useful for treating pain | |
| BR0210122A (pt) | Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo | |
| NO20065060L (no) | Farmasoytiske kombinasjoner inneholdende benzoksazin for behandling av respiratoriske forstyrrelser | |
| NO20045486L (no) | Nye forbindelser og deres anvendelse | |
| NO20052699L (no) | 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser. | |
| DK1664041T3 (da) | Phenylcarboxamidforbindelser, der er egnede til behandling af smerter | |
| EA200701181A1 (ru) | Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний | |
| DE69834500D1 (de) | Xanthinderivative zur behandlung von hirnischämie | |
| DE60035429D1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| NO20050903L (no) | Nye piperazinyl-pyrazinonderivater for behandling av 5HT-2A reseptorrelaterte forstyrrelser | |
| DE69500673T2 (de) | Arzneimittel zur therapeutischen und prophylaktischen Behandlung von Krankheiten, die durch Hyperplasie der glatten Muskelzellen bedingt sind | |
| DK1637517T3 (da) | 2-Amino-bicyclo[3.1.0]hexan-2,6-dicarboxylsyreesterderivat | |
| ATE409038T1 (de) | Verwendung eines hydroximinsäure-halogenid- derivats bei der behandlung von neurodegenerativen erkrankungen | |
| KR950032171A (ko) | 옥소피리디닐퀴녹살린 유도체 |